1. Home
  2. TGLS vs IRON Comparison

TGLS vs IRON Comparison

Compare TGLS & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tecnoglass Inc.

TGLS

Tecnoglass Inc.

HOLD

Current Price

$42.78

Market Cap

2.5B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$59.61

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGLS
IRON
Founded
1984
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
TGLS
IRON
Price
$42.78
$59.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
12
Target Price
$67.50
$101.67
AVG Volume (30 Days)
512.2K
582.0K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.38%
N/A
EPS Growth
N/A
N/A
EPS
3.42
N/A
Revenue
$370,984,000.00
N/A
Revenue This Year
$13.46
N/A
Revenue Next Year
$9.77
$101.57
P/E Ratio
$12.75
N/A
Revenue Growth
17.98
N/A
52 Week Low
$40.72
$30.82
52 Week High
$90.34
$99.50

Technical Indicators

Market Signals
Indicator
TGLS
IRON
Relative Strength Index (RSI) 37.07 38.62
Support Level $40.72 $57.81
Resistance Level $54.59 $64.00
Average True Range (ATR) 2.04 2.89
MACD 0.00 0.06
Stochastic Oscillator 30.68 16.99

Price Performance

Historical Comparison
TGLS
IRON

About TGLS Tecnoglass Inc.

Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: